Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Female hair loss linked to metabolic syndrome, not in males.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

The document concludes that signs of male and female pattern baldness include uneven hair thickness, yellow spots, skin discoloration around hair follicles, more thin and soft hairs, and many hair follicles with just one hair.

More men than women have hair loss, it's often inherited, and it's linked with higher testosterone levels. There's been a rise in female hair loss patients.

Female pattern baldness may indicate a higher risk of coronary artery disease.

Hair loss in women with PCOS is linked to high androgen levels but the relationship is unclear.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.

Women with PCOS and hair loss have lower levels of the protein gelsolin in their blood.

Low-level laser therapy effectively treats female hair loss, increasing hair count by 51%.

Hair loss common in men and women, limited treatments available.

Minoxidil helps treat pattern hair loss in both men and women.

Photobiomodulation helps hair growth safely in men and women, with laser devices working better than LED ones.

Cyproterone acetate can cause rare shortness of breath in women.

Low-dose oral minoxidil is effective and safe for treating hair loss in men and women.

Various treatments for common hair loss in men and women are effective, but should be tailored to individual needs and potential side effects.

Platelet-Rich Plasma injections can effectively reduce hair thinning and loss, especially in women.

Micrografts are a safe and effective treatment for hair loss in both men and women.

Androgenetic alopecia is a genetic hair loss condition, more severe in men, and can also be caused by hormonal imbalances in women.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Hair loss in adults is linked to heart disease risk factors like unhealthy blood fats, lack of exercise, and alcohol use. It's also slightly more common in people with metabolic syndrome. As people age, hair loss gets worse. In men, severe hair loss is tied to high blood pressure and a larger waist. In women, it's tied to higher body weight. People with hair loss should be checked for unhealthy blood fats and advised to avoid alcohol and inactivity.

Most older adults experience pattern hair loss due to shrinking hair follicles, with men and women showing different balding patterns.

Platelet-rich plasma injections can effectively reduce hair thinning, especially in women.

The most common treatment for hair loss in the study was a 5% minoxidil solution, with women more likely to receive multiple medications. A significant number of patients also had hypothyroidism.

Hair loss can cause significant social and emotional issues, especially for women and young men.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Hospital staff have a higher rate of hair loss than the general population.

The study concluded that women with female pattern hair loss had higher waist circumference, triglyceride levels, lower HDL, and blood glucose levels compared to those without hair loss.